After thirteen years with Carbogen Amcis, the last three of which he served as Chief Executive Officer (CEO), Pascal Villemagne has announced his intent to step down. He will remain in his role until ...

CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has appointed Amy Hay as Chief Business Officer and ...

Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new facilities, strategically positioned across key global markets ...

Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a Memorandum of Understanding which ...

Affinia Therapeutics, a gene therapy company with a pipeline of adeno-associated virus (AAV) gene therapies for devastating ...

In this webinar, Wayne Woodard, Chief Executive Officer of Argonaut Manufacturing Services, and Katie Edgar, Chief Business Officer of KBI Biopharma discuss the challenges unique to organizations ...

Additionally, as the Sandoz spin-off was completed on October 2023, there were no operating results in 2024 related to discontinued operations.